Neonatal cellular and gene therapies for mucopolysaccharidoses: the earlier the better?
Mucopolysaccharidoses (MPSs) are a group of lysosomal storage disorders (LSDs). The increasing interest in newborn screening procedures for LSDs underlines the need for alternative cellular and gene therapy approaches to be developed during the perinatal period, supporting the treatment of MPS patie...
Main Authors: | Tomatsu, Shunji, Azario, Isabella, Sawamoto, Kazuki, Pievani, Alice Silvia, Biondi, Andrea, Serafini, Marta |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer Netherlands
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754332/ |
Similar Items
-
Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I
by: Isabella Azario, et al.
Published: (2017-08-01) -
Establishment of Glycosaminoglycan Assays for Mucopolysaccharidoses
by: Tomatsu, Shunji, et al.
Published: (2014) -
Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential
by: Pievani, Alice, et al.
Published: (2014) -
Lactate clearance: the earlier the better?
by: Guiotto, G, et al.
Published: (2008) -
Pentosan Polysulfate: A Novel Therapy for the Mucopolysaccharidoses
by: Schuchman, Edward H., et al.
Published: (2013)